Navigation Links
BIO CEO & Investor 2008 Conference to Webcast Millennium Presentation
Date:2/4/2008

CAMBRIDGE, Mass., Feb. 4 /PRNewswire-FirstCall/ -- Millennium Pharmaceuticals, Inc. (Nasdaq: MLNM) today announced that its presentation at the BIO CEO & Investor 2008 Conference will be webcast live and may be accessed by visiting the Investors section of the Company's website, http://www.millennium.com.

(Logo: http://www.newscom.com/cgi-bin/prnh/19991220/MLNMLOGO )

The presentation will include an overview of the Company, VELCADE(R) (bortezomib) for Injection, other product candidates and upcoming corporate events. The presentation will be delivered at 11:45 a.m. ET on Monday, February 11, 2007 from the Waldorf Astoria Hotel in New York, NY. The presentation will be archived for 30 days.

About Millennium

Millennium Pharmaceuticals, Inc., a leading biopharmaceutical company based in Cambridge, Mass., markets VELCADE(R) (bortezomib) for Injection, a novel cancer product, and has a robust clinical development pipeline of product candidates. The Company's research, development and commercialization activities are focused in two therapeutic areas: oncology and inflammation. By applying its knowledge of the human genome, understanding of disease mechanisms and industrialized drug discovery platform, Millennium is developing an exciting pipeline of innovative product candidates. The Company's website is http://www.millennium.com.

Editors' Note: This press release is also available under the Media section of the Company's website at: http://www.millennium.com.

Contact:

Kyle Kuvalanka

(617) 761-4734


'/>"/>
SOURCE Millennium Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
2. Skinvisible to Present at Merriman Curhan Ford & Co.s Investor Summit 2007
3. DURECT to Present at Merriman Curhan Fords Annual Investor Summit
4. Exponent to Present at the Upcoming Sidoti & Company Investor Forum and William Blair Small-Cap Growth Stock Conference
5. Stryker to Present at Investor Conference
6. AMERIGROUP Corporation to Host Investor Day
7. Milestone Scientific to Present at the Edgewater Research Investor Conference
8. Transcept Pharmaceuticals, Inc. to Present at 2007 BIO Investor Forum
9. Par Pharmaceutical Provides Summary of Analyst/Investor Day
10. Sunnylife Global Retains The Blaine Group For Investor Relations, Financial Public Relations
11. SGX Pharmaceuticals to Present at the BIO InvestorForum 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/19/2017)... (PRWEB) , ... August 18, 2017 , ... ... partnership aimed at creating a transparent, verifiable database to help the cannabis industry ... ledger technology, Paragon hopes to deliver a faster technology with lower fees. Paragon ...
(Date:8/19/2017)... ... August 19, 2017 , ... Yesterday, the President of the United ... are two sides. There are not two sides to hatred, bigotry, discrimination, and a ... prejudice, and the NPEIV stands against all forms of such hatred and discrimination in ...
(Date:8/18/2017)... ... ... More than 20,000 pairs of shoes made their way across the Atlantic ... that conjoined the passions of an NBA star, a Liberty University student, and an ... will save lives from the rampant infections transmitted through the soil. , AMERICAN SOLES ...
(Date:8/18/2017)... ... August 18, 2017 , ... ... Hearing” campaign, advocating for active, healthy lifestyles and highlighting the importance of proactive ... with hearing impairments and shares the latest innovations in hearing aid technology. ...
(Date:8/18/2017)... ... August 18, 2017 , ... ... services to communities in east Texas, is launching a regional charity effort to ... Founded in 1991, the Pediatric Brain Tumor Foundation (PBTF) has raised nearly $30 ...
Breaking Medicine News(10 mins):
(Date:8/11/2017)... , Aug. 11, 2017 DarioHealth Corp. (NASDAQ: ... health and big data solutions, today announced that it ... August 14 and host a conference call at 9:00am ... operating and financial results and its strategy and outlook ... hosted by Erez Raphael , Chief Executive Officer, ...
(Date:8/7/2017)... Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), ... Board of Directors has approved the payment of a quarterly ... The cash dividend of ... 27, 2017 to stockholders of record as of the close ... are subject to approval of the Board of Directors and ...
(Date:8/4/2017)... -- Agragen, LLC, a Cincinnati -based ... and aquacultural feed sectors, announces a significant step ... AGR131.  This drug is designed to trap and ... patients suffering from inflammatory conditions such as rheumatoid ... Biological pharmaceuticals currently used ...
Breaking Medicine Technology: